Consideration of Uncertainty in Making Benefit-Risk Determinations in Medical Device Premarket Approvals, De Novo Classifications, and Humanitarian Device Exemptions: Guidance for Industry and Food and Drug Administration Staff

Information

Type

Guidance

Regulated products

Medical Devices

Topics

Postmarket, Premarket

Published

August 30, 2019

Last updated

August 29, 2019

Description

This document is a guidance for industry and FDA staff on considering uncertainty in benefit-risk determinations for medical devices.

Organization

Country / Region

United States

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed